Pharmacovigilance and Risk Management Strategies Conference

Benefit risk evaluation is key to decision-making for most stakeholders involved with innovative medicines. Whereas regulators evaluate it at a population based level, healthcare professionals and patients need to understand how it affects them at the individual level: “Is drug A the right treatment for me/my patient?” This session will explore different measures for looking at benefit risk and new ways in which the data can be visualized to facilitate decision making. A system which helps integrate evidence across different data sources for signal analysis will be demonstrated.